PASMI Polish Association of Self Medication Industry, as of 6 November this year took over the chairmanship and administrative support of the Disciplinary Court established under the Code of Good Practices of Advertising Food Supplements. The chairmanship of the Court is rotary and performed by organizations that have signed the Code. PASMI will play this role for the next 6 months, i.e. until 5 May 2019.
The task of the Disciplinary Court is to deal with complaints submitted by the Code signatories, which protect the observance of its provisions.
“The Code introduces additional requirements as to how advertise food supplements, such as the obligation to include information about the product category or prohibition of using the image or recommendation of a doctor and pharmacist. Additional requirements have already been introduced by advertisers and are adhered to, as can be seen in the broadcast advertising spots” – says PASMI President Ewa Jankowska.
The Code of Good Practices of Advertising Food Supplements was drafted at the initiative of the industry as a response to the demand in the area of raising awareness and providing consumer education, as well as creating and organizing high standards in terms of communication, promotion and advertising of food supplements. The Code is a collection of good practices that set out the directions of action in informing the consumer about this category of foodstuffs, as well as in accordance with the rules of presenting the above-mentioned products in advertisements so that they are not confused with drugs.
PASMI Polish Association of Self Medication Industry promotes the responsible self-medication among the society through a conscious and safe use of products classified as drugs sold without Prescription. It pursues to establish relevant legal and systematic solutions for the development of the responsible use of OTC drugs as one of the elements of the healthcare system.
PASMI cooperates actively with European organisations whose goals and operations are in line with the statutory activity of PASMI. PASMI is a member of AESGP – Association of the European Self-Medication Industry. Currently, the Association has 20 members: Aboca, A&D Pharma, Adamed, Bayer, Biocodex, GSK, Johnson&Johnson, Klosterfrau, Omega Pharma Poland, Queisser Pharma, Pfizer, Polpharma, Reckitt Benckiser, Sanofi, Takeda, Teva, USP Zdrowie, Verco, Walmark and Polski Komitet Zielarski as a supporting member.